Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...

Tea quality depends on coordinated leaf growth and metabolite accumulation, yet the cellular mechanisms underlying this ...

Stem-cell–based therapies aim to change that paradigm by repairing or replacing damaged biological systems. If replicated successfully in larger patient populations, the approach could reduce ...

After treatment, the mice’s memories were essentially shunted back into a younger state. The researchers found that reprogrammed engrams displayed molecular behavior of more youthful cells. Using a ...

CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now ...

KLF5 appears to fuel pancreatic cancer metastasis by reprogramming epigenetic controls, offering a potential new therapeutic target.

Despite offering great hope for regenerative medicine, the international scientific community is expressing deep concern ...

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.

Ordinary fat cells in obese animals can be induced to burn energy stores, generating substantial heat, according to a ...